Comprehensive Hereditary Cancer Panel 154 genes Test
Test Name: Comprehensive Hereditary Cancer Panel 154 genes Test
Components: EDTA Vacutainer (2ml)
Price: 7200.0 AED
Sample Condition: Peripheral Blood
Report Delivery: 4-6 weeks
Method: NGS (Next-Generation Sequencing)
Test Type: Genetics
Doctor: General Physician
Test Department: Pre Test Information
Comprehensive Hereditary Cancer Panel (154 genes) can be done with a doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Test Details
The Comprehensive Hereditary Cancer Panel (154 genes) is a genetic test that analyzes a person’s DNA for mutations or changes in 154 genes associated with an increased risk of developing hereditary cancers. These genes are involved in various biological pathways, including DNA repair, cell growth and division, and tumor suppression.
The panel includes genes associated with a wide range of cancers, including breast, ovarian, colorectal, pancreatic, prostate, and melanoma. The test can help identify individuals who may have an increased risk of developing cancer and provide information that can guide personalized screening and prevention strategies.
The test is typically recommended for individuals with a personal or family history of cancer, particularly those with a known or suspected hereditary cancer syndrome. It may also be recommended for individuals who have been diagnosed with cancer at a young age or have multiple primary cancers.
The test involves a blood or saliva sample, which is analyzed using next-generation sequencing technology. Results are typically available within a few weeks and are interpreted by a genetic counselor or healthcare provider trained in genetics.
It is important to note that a positive result on the panel does not necessarily mean that an individual will develop cancer, but it does indicate an increased risk. Additional screening and prevention measures may be recommended based on the individual’s specific genetic findings and personal and family history of cancer.
Test Name | Comprehensive Hereditary Cancer Panel 154 genes Test |
---|---|
Components | EDTA Vacutainer (2ml) |
Price | 7200.0 AED |
Sample Condition | Peripheral Blood |
Report Delivery | 4-6 weeks |
Method | NGS |
Test type | Genetics |
Doctor | General Physician |
Test Department: | |
Pre Test Information | Comprehensive Hereditary Cancer Panel (154 genes) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details |
The Comprehensive Hereditary Cancer Panel (154 genes) is a genetic test that analyzes a person’s DNA for mutations or changes in 154 genes associated with an increased risk of developing hereditary cancers. These genes are involved in various biological pathways, including DNA repair, cell growth and division, and tumor suppression. The panel includes genes associated with a wide range of cancers, including breast, ovarian, colorectal, pancreatic, prostate, and melanoma. The test can help identify individuals who may have an increased risk of developing cancer and provide information that can guide personalized screening and prevention strategies. The test is typically recommended for individuals with a personal or family history of cancer, particularly those with a known or suspected hereditary cancer syndrome. It may also be recommended for individuals who have been diagnosed with cancer at a young age or have multiple primary cancers. The test involves a blood or saliva sample, which is analyzed using next-generation sequencing technology. Results are typically available within a few weeks and are interpreted by a genetic counselor or healthcare provider trained in genetics. It is important to note that a positive result on the panel does not necessarily mean that an individual will develop cancer, but it does indicate an increased risk. Additional screening and prevention measures may be recommended based on the individual’s specific genetic findings and personal and family history of cancer. |